Todd Foley's Net Worth

$598 Million

Who is Todd Foley?

Todd Foley has an estimated net worth of $598 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., iTeos Therapeutics, Inc., TriVascular Technologies, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Dyne Therapeutics, Inc., Celladon Corp, Verastem, Inc., Syndax Pharmaceuticals Inc, Harpoon Therapeutics, Inc., ARATANA THERAPEUTICS, INC., TCR2 THERAPEUTICS INC., Conatus Pharmaceuticals Inc, TURMERIC ACQUISITION CORP., Epizyme, Inc., Werewolf Therapeutics, Inc., Cerecor Inc., Oncorus, Inc., Radius Health, Inc., Zalicus Inc., CHIASMA, INC, and Pacira Pharmaceuticals, Inc..

SEC CIK

Todd Foley's CIK is 0001473930

Past Insider Trading and Trends

2020 was Todd Foley's most active year for acquiring shares with 29 total transactions. Todd Foley's most active month to acquire stocks was the month of June. 2021 was Todd Foley's most active year for disposing of shares, totalling 158 transactions. Todd Foley's most active month to dispose stocks was the month of May. 2019 saw Todd Foley paying a total of $14,121,250.25 for 8,086,849 shares, this is the most they've acquired in one year. In 2021 Todd Foley cashed out on 61,795,693 shares for a total of $94,405,436.05, their largest year based on trade value.